Nirmala Pathmanathan

Summary

Affiliation: New South Wales
Country: Australia

Publications

  1. doi A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast
    Nirmala Pathmanathan
    Department of Tissue Pathology, Institute of Clinical Pathology and Medical Research, Sydney West Area Health Service, New South Wales, Australia
    Pathology 42:28-36. 2010
  2. doi Diagnostic evaluation of papillary lesions of the breast on core biopsy
    Nirmala Pathmanathan
    Department of Tissue Pathology, Institute of Clinical Pathology and Medical Research, Sydney West Area Health Service, Westmead, NSW, Australia
    Mod Pathol 23:1021-8. 2010
  3. ncbi The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer
    Nirmala Pathmanathan
    Westmead Breast Cancer Institute, Westmead Hospital, Westmead, New South Wales, Australia
    J Clin Pathol 67:222-8. 2014
  4. doi Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families
    Rosemary L Balleine
    Translational Oncology, Sydney West Area Health Service, Sydney, Australia
    Genes Chromosomes Cancer 49:1082-94. 2010
  5. doi Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing
    Nirmala Pathmanathan
    Department of Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, NSW 2145, Australia
    Breast 21:724-9. 2012
  6. ncbi Histiocytoid change in breast carcinoma: a report of 3 cases with an unusual cytomorphologic pattern of apocrine change
    Rajmohan Murali
    Department of Tissue Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, NSW, Australia
    Acta Cytol 50:548-52. 2006
  7. ncbi Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: initial experience and lessons learnt in establishing a new practice
    Nirmala Pathmanathan
    Tissue Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia
    Pathology 38:321-7. 2006
  8. doi Ki67 and proliferation in breast cancer
    Nirmala Pathmanathan
    Westmead Breast Cancer Institute, Westmead Hospital, Westmead, New South Wales, Australia
    J Clin Pathol 66:512-6. 2013

Detail Information

Publications8

  1. doi A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast
    Nirmala Pathmanathan
    Department of Tissue Pathology, Institute of Clinical Pathology and Medical Research, Sydney West Area Health Service, New South Wales, Australia
    Pathology 42:28-36. 2010
    ..The aim of this study was to identify distinct CCL subtypes by systematic analysis of histopathology...
  2. doi Diagnostic evaluation of papillary lesions of the breast on core biopsy
    Nirmala Pathmanathan
    Department of Tissue Pathology, Institute of Clinical Pathology and Medical Research, Sydney West Area Health Service, Westmead, NSW, Australia
    Mod Pathol 23:1021-8. 2010
    ..This approach may form a useful addition to the clinicopathologic evaluation of papillary lesions of the breast...
  3. ncbi The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer
    Nirmala Pathmanathan
    Westmead Breast Cancer Institute, Westmead Hospital, Westmead, New South Wales, Australia
    J Clin Pathol 67:222-8. 2014
    ..To evaluate the utility of Ki67 as a prognostic marker in a series of patients with node-negative breast cancer untreated with adjuvant systemic therapy...
  4. doi Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families
    Rosemary L Balleine
    Translational Oncology, Sydney West Area Health Service, Sydney, Australia
    Genes Chromosomes Cancer 49:1082-94. 2010
    ..237). The pattern of breast cancer pathology concordance amongst family members may assist the investigation of breast cancer susceptibility in multiple case families...
  5. doi Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing
    Nirmala Pathmanathan
    Department of Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, NSW 2145, Australia
    Breast 21:724-9. 2012
    ..3%. The phenotype of HER2+ breast cancer was stable following the introduction of universal testing. The overall rate of HER2+ breast cancer was influenced by screen detection...
  6. ncbi Histiocytoid change in breast carcinoma: a report of 3 cases with an unusual cytomorphologic pattern of apocrine change
    Rajmohan Murali
    Department of Tissue Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, NSW, Australia
    Acta Cytol 50:548-52. 2006
    ..Breast carcinomas composed predominantly or exclusively of cells with foamy and/or granular cytoplasm have been termed histiocytoid breast carcinoma...
  7. ncbi Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: initial experience and lessons learnt in establishing a new practice
    Nirmala Pathmanathan
    Tissue Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia
    Pathology 38:321-7. 2006
    ..The learning process is compared with published results from institutions with many years of experience in order to assess progress in reaching those ideal results, and the methodology used by these institutions is reviewed...
  8. doi Ki67 and proliferation in breast cancer
    Nirmala Pathmanathan
    Westmead Breast Cancer Institute, Westmead Hospital, Westmead, New South Wales, Australia
    J Clin Pathol 66:512-6. 2013
    ..In this circumstance, pathologists must establish a standardised framework for scoring Ki67 and communicating results to a multidisciplinary team...